Chronic graft-versus-host disease in the era of reduced-intensity conditioning

被引:15
|
作者
Subramaniam, D. S.
Fowler, D. H.
Pavletic, S. Z.
机构
[1] NCI, Graft Versus Host & Autoimmun Unit, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA
[2] Georgetown Univ Hosp, Lombardi Canc Ctr, Div Hematol Oncol, Washington, DC 20007 USA
关键词
chronic graft-versus-host disease; reduced-intensity conditioning; hematopoietic stem cell transplantation;
D O I
10.1038/sj.leu.2404642
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the past decade the field of hematopoietic stem cell transplantation has entered a new era with the introduction of reduced intensity conditioning (RIC) regimens. The impact of RIC on the incidence of chronic graft-versus-host disease (GVHD) has not been evaluated systematically. Factors confounding such analyses include short follow-up in studies, absence of prospective comparison trials, use of a variety of RIC regimens, lack of uniform GVHD prophylaxis and lack of rigorous criteria for the diagnosis and staging of chronic GVHD. This review discusses factors that appear to influence the incidence and clinical presentation of chronic GVHD in the RIC transplantation era. Overall, RIC seems to decrease the incidence and severity of acute GVHD through day 100 posttransplant when compared to conventional conditioning; however, there is little evidence to suggest that chronic GVHD is reduced after RIC. For the more definitive assessments of chronic GVHD after RIC it will be important to study this question in prospective comparison trials with long duration of follow-up. The recent National Institutes of Health chronic GVHD consensus project recommendations provide now the critically needed standardized guidelines for the diagnosis, classification and staging of chronic GVHD.
引用
收藏
页码:853 / 859
页数:7
相关论文
共 50 条
  • [1] Chronic graft-versus-host disease in the era of reduced-intensity conditioning
    D S Subramaniam
    D H Fowler
    S Z Pavletic
    Leukemia, 2007, 21 : 853 - 859
  • [2] Chronic graft-versus-host disease after allogeneic reduced-intensity conditioning haematopoietic stem cell transplantations
    Michallet, M.
    Le, Q.
    Raus, N.
    Sobh, M.
    Revesz, D.
    Thiebaut, A.
    Thomas, X.
    Chelgoum, Y.
    Ducastelle, S.
    Troncy, J.
    Clark, M.
    Nicolini, F.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S119 - S119
  • [3] Predicting death in patients with acute graft-versus-host disease after reduced-intensity conditioning
    Weissinger, Eva M.
    Ganser, Arnold
    LANCET HAEMATOLOGY, 2017, 4 (09): : E400 - E401
  • [4] Cytokines dysregulation and chronic graft-versus-host disease after allogeneic haematopoietic stem cells transplantation with reduced-intensity conditioning
    Skert, C
    Damiani, D
    Michelutti, A
    Stocchi, R
    Calistri, E
    Patriarca, F
    Cerno, M
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S151 - S151
  • [5] Less chronic graft-versus-host disease with reduced-intensity conditioning than myeloablative conditioning in HLA-matched sibling donor transplant
    Alessandrino, E. P.
    Colombo, A. A.
    Bernasconi, P.
    Caldera, D.
    Gotti, M.
    Ripamonti, F.
    Zaniboni, A.
    Pascutto, C.
    Lazzarino, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S336 - S336
  • [6] Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases
    Crocchiolo, Roberto
    Esterni, Benjamin
    Castagna, Luca
    Fuerst, Sabine
    El-Cheikh, Jean
    Devillier, Raynier
    Granata, Angela
    Oudin, Claire
    Calmels, Boris
    Chabannon, Christian
    Bouabdallah, Reda
    Vey, Norbert
    Blaise, Didier
    CANCER, 2013, 119 (05) : 986 - 992
  • [7] Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    Blaise, D
    Faucher, C
    Vey, N
    Bouabdallah, R
    Stoppa, AM
    Viret, F
    Gravis, G
    Olive, D
    Gaugler, B
    BLOOD, 2005, 106 (13) : 4407 - 4411
  • [8] The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo
    Massi, Daniela
    Fondi, Cristina
    Nozzoli, Chiara
    Benemei, Silvia
    Lapi, Francesco
    Albarello, Luca
    Avellini, Claudio
    Bonoldi, Emanuela
    Casini, Marco
    Cesinaro, Anna Maria
    Ciceri, Fabio
    Colombetti, Vito
    Comin, Camilla Eva
    Donelli, Amedea
    Fortunato, Mirella
    Fratoni, Stefano
    Guidi, Stefano
    Messerini, Luca
    Milone, Giuseppe
    Rapezzi, Davide
    Negri, Giovanni
    Patriarca, Francesca
    Peccatori, Fedro Alessandro
    Ponzoni, Maurilio
    Rafaniello, Paola
    Raimondi, Roberto
    Salomone, Edvige
    Tendas, Andrea
    Villari, Loredana
    Santucci, Marco
    Bosi, Alberto
    HUMAN PATHOLOGY, 2011, 42 (02) : 254 - 268
  • [9] Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation
    Busca, A
    Rendine, S
    Locatelli, F
    Sizzano, F
    Dall'Omo, AM
    Rossi, G
    Falda, M
    HEMATOLOGY, 2005, 10 (01) : 1 - 10
  • [10] Antithymocyte Globulin in Reduced-Intensity Conditioning Regimen Allows a High Disease-Free Survival Exempt of Long-Term Chronic Graft-versus-Host Disease
    Devillier, Raynier
    Fuerst, Sabine
    El-Cheikh, Jean
    Castagna, Luca
    Harbi, Samia
    Granata, Angela
    Crocchiolo, Roberto
    Oudin, Claire
    Mohty, Bilal
    Bouabdallah, Reda
    Chabannon, Christian
    Stoppa, Anne-Marie
    Charbonnier, Aude
    Broussais-Guillaumot, Florence
    Calmels, Boris
    Lemarie, Claude
    Rey, Jerome
    Vey, Norbert
    Blaise, Didier
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (03) : 370 - 374